日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ProSeg: multi-scale context fusion for high-precision prostate segmentation in MRI

ProSeg:用于MRI中前列腺高精度分割的多尺度上下文融合

Qin, Jiangwei; Yang, Yanli

Inhibition of primary ciliogenesis enhances efficacy of EGFR‑TKIs against non‑small cell lung cancer cells.

抑制原发性纤毛发生可增强 EGFR-TKIs 对非小细胞肺癌细胞的疗效。

Jin Liangliang, Wei Li, Hua Junrui, Zhang Rong, Chen Jiaxin, He Jinpeng, Yang Yanli

Six-minute walk distance predicting the risk of mortality in lymphangioleiomyomatosis patients

六分钟步行距离可预测淋巴管肌瘤病患者的死亡风险

Yang, Luning; Zhang, Xiaoxin; Wang, Luyi; Cheng, Chongsheng; Wang, Hanghang; Zhang, Miaoyan; Liu, Song; Xu, Wenshuai; Liu, Junya; Dai, Jinrong; Meng, Shuzhen; Yang, Yanli; Wang, Shao-Ting; Tian, Xinlun; Xu, Kai-Feng

MDSC subpopulation dynamics predict disease evolution: a multidimensional biomarker framework for risk assessment in MDS

MDSC亚群动态变化预测疾病进展:MDS风险评估的多维生物标志物框架

Hu, ZhongLi; Hu, ZhongTing; Zhang, YongYu; Hua, MengQing; Huang, ShaoJie; Wang, YuXian; Yang, YanLi; Zhao, Ping; Zhou, Yu

Erratum: [Corrigendum] miR-185 enhances the inhibition of proliferation and migration induced by ionizing radiation in melanoma

勘误:[更正] miR-185 增强电离辐射对黑色素瘤细胞增殖和迁移的抑制作用

He, Jinpeng; Tian, Ning; Yang, Yanli; Jin, Liangliang; Feng, Xiu; Hua, Junrui; Lin, Sulan; Wang, Bing; Li, He; Wang, Jufang

Postoperative Adjuvant Chemoradiotherapy ± PD-1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma

局部晚期头颈部鳞状细胞癌术后辅助放化疗±PD-1抑制剂治疗

Wang, Zhiqiang; He, Qingqing; Jiang, Donghui; Cheng, Sheng; Gao, Jingyu; Wang, Yan; Fu, Shuai; Cui, Qing Ying; Yang, Yanli; Lv, Li; Xu, Yuchuan; Li, Yan; Tian, Rui; Ge, Chunlei; Li, Rongqing

Short-term response to alectinib and rapid progression in a lung squamous cell carcinoma patient harboring an EML4-ALK fusion: a case report

一例携带EML4-ALK融合基因的肺鳞状细胞癌患者对阿来替尼治疗短期有效但病情迅速进展:病例报告

Li, Shengshu; Du, Xiaosong; Zhang, Xinxin; Ma, Haixia; Yang, Yanli; Li, Yuan; Wei, Qin; Chen, Yan; Li, Hongwei; Bu, Peng; Liu, Dujuan; Han, Songyan; Chen, Deyi

Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma

zevorcabtagene autoleucel(一种全人源BCMA靶向CAR-T细胞疗法)治疗复发/难治性多发性骨髓瘤患者的II期研究

Chen, Wenming; Fu, Chengcheng; Fang, Baijun; Liang, Aibin; Xia, Zhongjun; He, Yanjuan; Lu, Jin; Liu, Hui; Hou, Ming; Cai, Zhen; Yang, Wei; Hao, Siguo; Jiang, Songfu; Jing, Hongmei; Liu, Jing; Du, Xin; Fu, Rong; Mei, Heng; Zhu, Zunmin; Yang, Yanli; Liu, Hong; Meng, Xingxing; Rajakumaraswamy, Nishanthan; Yuan, Daijing; Wang, Huamao; Li, Zonghai

Aberrant lipid profiles and lymphocyte counts in systemic sclerosis population, reassessing predictive value for concurrent cardiovascular diseases

系统性硬化症患者异常的血脂谱和淋巴细胞计数,重新评估其对并发心血管疾病的预测价值

Guo, Ronghong; Gao, Jinfang; Yang, Yanli; Xu, Ke

Advances in the mechanisms, imaging characteristics and management strategies for immune checkpoint inhibitor-related pneumonitis

免疫检查点抑制剂相关性肺炎的机制、影像学特征和治疗策略方面的进展

Li, Shengshu; Geng, Ziying; Hong, Shuang; Zhang, Jianxin; Yang, Yanli; Wei, Qin; Zhang, Xinxin; Zhuang, Xiaofei; Huo, Rujie; Han, Songyan; Wang, Jie